Display options
Cite
Zhang Y, Tian S, Liu Z, et al. Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology. 2014;3(10):e959321doi: 10.4161/21624011.2014.959321.
Zhang, Y., Tian, S., Liu, Z., Zhang, J., Zhang, M., Bosenberg, M. W., Kedl, R. M., Waldmann, T. A., Storkus, W. J., Falo, L. D., & You, Z. (2014). Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology, 3(10), e959321. https://doi.org/10.4161/21624011.2014.959321
Zhang, Yi, et al. "Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency." Oncoimmunology vol. 3,10 (2014): e959321. doi: https://doi.org/10.4161/21624011.2014.959321
Zhang Y, Tian S, Liu Z, Zhang J, Zhang M, Bosenberg MW, Kedl RM, Waldmann TA, Storkus WJ, Falo LD, You Z. Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology. 2014 Dec 15;3(10):e959321. doi: 10.4161/21624011.2014.959321. eCollection 2014 Nov. PMID: 25941586; PMCID: PMC4292719.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2014 Dec 15;3(10):e959321. doi: 10.4161/21624011.2014.959321. eCollection 2014 Nov.

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

Oncoimmunology

Yi Zhang, Shenghe Tian, Zuqiang Liu, Jiying Zhang, Meili Zhang, Marcus W Bosenberg, Ross M Kedl, Thomas A Waldmann, Walter J Storkus, Louis D Falo, Zhaoyang You

Affiliations

  1. Department of Dermatology; University of Pittsburgh School of Medicine ; Pittsburgh, PA USA.
  2. Lymphoid Malignancies Branch; Center for Cancer Research, National Cancer Institute ; Bethesda, MD USA.
  3. Departments of Dermatology and Pathology; Yale University School of Medicine ; New Haven, CT USA.
  4. Department of Immunology and Microbiology; University of Colorado ; Aurora, CO USA.
  5. Department of Dermatology; University of Pittsburgh School of Medicine ; Pittsburgh, PA USA ; Department of Immunology; University of Pittsburgh School of Medicine ; Pittsburgh, PA USA ; University of Pittsburgh Cancer Institute ; Pittsburgh, PA USA.

PMID: 25941586 PMCID: PMC4292719 DOI: 10.4161/21624011.2014.959321

[No abstract available.]

Keywords: DC; IL-15; cancer vaccines

References

  1. Eur J Immunol. 2003 Dec;33(12):3493-503 - PubMed
  2. Immunity. 2013 Jul 25;39(1):38-48 - PubMed
  3. Clin Cancer Res. 2010 Dec 15;16(24):6019-28 - PubMed
  4. Immunol Rev. 2008 Apr;222:357-68 - PubMed
  5. J Immunol. 2005 Jul 1;175(1):112-23 - PubMed
  6. Gene Ther. 2009 Oct;16(10):1260-70 - PubMed
  7. J Exp Med. 2004 Sep 20;200(6):761-70 - PubMed
  8. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8158-63 - PubMed
  9. J Exp Med. 2008 May 12;205(5):1213-25 - PubMed
  10. Cancer Res. 2010 Feb 1;70(3):1072-81 - PubMed
  11. Eur J Immunol. 2007 Jun;37(6):1678-90 - PubMed
  12. Gene Ther. 2001 Apr;8(8):608-17 - PubMed
  13. Clin Vaccine Immunol. 2008 Jan;15(1):131-7 - PubMed
  14. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):588-93 - PubMed
  15. J Exp Med. 2011 Sep 26;208(10):1989-2003 - PubMed
  16. Science. 2003 Feb 14;299(5609):1033-6 - PubMed
  17. J Leukoc Biol. 2011 Jul;90(1):205-14 - PubMed
  18. Vaccine. 2009 Dec 11;28(2):561-70 - PubMed
  19. Nat Genet. 2009 May;41(5):544-52 - PubMed
  20. Gene Ther. 2014 Apr;21(4):393-401 - PubMed
  21. Blood. 2005 Oct 1;106(7):2433-5 - PubMed
  22. Nat Rev Immunol. 2009 Mar;9(3):162-74 - PubMed
  23. Science. 2008 Nov 14;322(5904):1097-100 - PubMed
  24. Mol Ther. 2012 Feb;20(2):432-42 - PubMed
  25. J Exp Med. 2001 Jan 15;193(2):219-31 - PubMed
  26. Nat Immunol. 2012 Dec;13(12):1187-95 - PubMed
  27. Blood. 2008 Dec 1;112(12):4546-54 - PubMed
  28. Cancer Res. 2003 Dec 1;63(23):8487-91 - PubMed
  29. Mol Ther. 2005 Jun;11(6):941-9 - PubMed
  30. Cancer Cell. 2012 Nov 13;22(5):645-55 - PubMed
  31. J Immunol. 2009 Dec 1;183(11):7250-8 - PubMed
  32. Nat Immunol. 2006 Jul;7(7):740-6 - PubMed
  33. Blood. 2011 Apr 14;117(15):4032-40 - PubMed
  34. Nat Rev Immunol. 2006 Aug;6(8):595-601 - PubMed
  35. Nature. 2011 Mar 10;471(7337):220-4 - PubMed
  36. Nat Med. 2006 Mar;12(3):335-41 - PubMed
  37. Cancer Res. 2008 Apr 15;68(8):2972-83 - PubMed
  38. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7513-8 - PubMed
  39. Stem Cells. 2000;18(1):10-8 - PubMed
  40. J Exp Med. 2006 Oct 2;203(10):2329-38 - PubMed
  41. Immunity. 2009 Nov 20;31(5):811-22 - PubMed
  42. Cancer Res. 2013 May 15;73(10):3075-86 - PubMed
  43. J Immunol. 2013 Mar 1;190(5):1936-47 - PubMed
  44. Mol Cancer Ther. 2009 Sep;8(9):2736-45 - PubMed
  45. Annu Rev Immunol. 2006;24:519-40 - PubMed
  46. J Exp Med. 2011 Sep 26;208(10):2005-16 - PubMed
  47. Mol Cancer Ther. 2012 Jun;11(6):1279-88 - PubMed
  48. Trends Immunol. 2013 Jan;34(1):33-40 - PubMed
  49. J Immunol. 2009 May 15;182(10):6160-7 - PubMed
  50. Hum Gene Ther. 2005 Nov;16(11):1255-66 - PubMed
  51. J Immunol. 2008 Dec 15;181(12):8237-47 - PubMed
  52. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5201-6 - PubMed
  53. Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6187-92 - PubMed
  54. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8662-7 - PubMed
  55. Blood. 2011 May 5;117(18):4787-95 - PubMed
  56. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54 - PubMed
  57. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9166-71 - PubMed

Publication Types